Skip to content
TrueView 100 Pro
Navigator System
Navigator System
Navigator Sterilization
MarginProbe
MarginProbe
Breast Cancer
Partial Mastectomy
Lumpectomy Surgery
Ductal Carcinoma in Situ (DCIS)
Lumpectomy Margins
Patients
MarginProbe Advantage
Physicians
Clinical Data
Hemoblast
Clinical Data
Economic Value
Surgical Videos
CoPilot VL
About
Careers
News
Contact
TrueView 100 Pro
Navigator System
Navigator System
Navigator Sterilization
MarginProbe
MarginProbe
Breast Cancer
Partial Mastectomy
Lumpectomy Surgery
Ductal Carcinoma in Situ (DCIS)
Lumpectomy Margins
Patients
MarginProbe Advantage
Physicians
Clinical Data
Hemoblast
Clinical Data
Economic Value
Surgical Videos
CoPilot VL
About
Careers
News
Contact
Contact
A Prospective, Randomized, Controlled, Multicenter Study of a Real-Time, Intraoperative Probe for Positive Margin Detection in Breast-Conserving Surgery.
January 6, 2008
/
Clinical Data
[vc_row][vc_column][vc_column_text]
View Study
[/vc_column_text][/vc_column][/vc_row]
Posted in
Clinical Data
Posts navigation
← Dilon Devices Honored with 2007 Frost & Sullivan European Technology Innovation of the Year Award for Novel Cancer Probe
Randomized, Controlled Multicenter Trial Demonstrates Safety and Clinical Benefit, Significant Reduction in Repeat Surgeries Enabled by Dune’s MarginProbe® →